HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiyuki Komori Selected Research

Orotate Phosphoribosyltransferase

8/2008Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
7/2008[Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
10/2007[Orotate phosphoribosyltransferase levels in gastric carcinoma and normal gastric mucosa - correlation with thymidylate synthase and dihydropyrimidine dehydrogenase levels and the changes after neoadjuvant chemotherapy].
1/2007Levels and expressions of orotate phosphoribosyltransferase in gastric carcinoma and normal gastric mucosa tissues.
8/2006[Clinical and prognostic significance of protein and gene expression of orotate phosphoribosyltransferase in gastric carcinoma].
6/2006Orotate phosphoribosyltransferase levels measured by a newly established enzyme-linked immunosorbent assay in gastric carcinoma.
4/2006[Clinicopathological significance of orotate phosphoribosyltransferase in gastric carcinoma].
7/2005[Establishment of enzyme-linked immunosorbent assay for quantification of orotate phosphoribosyltransferase in gastric carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiyuki Komori Research Topics

Disease

15Carcinoma (Carcinomatosis)
11/2010 - 08/2000
10Stomach Neoplasms (Stomach Cancer)
08/2008 - 08/2000
5Neoplasms (Cancer)
11/2010 - 01/2005
2Lymphatic Metastasis
07/2008 - 05/2005
1Hiatal Hernia
04/2011
1Intrathoracic Gastric Volvulus
04/2011
1Gastroesophageal Reflux (GERD)
04/2011
1Intestinal Volvulus (Volvulus)
04/2011
1Pain (Aches)
12/2010
1Vascular System Injuries
04/2009
1Dyspnea (Shortness of Breath)
04/2009
1Pleural Effusion (Pleural Effusions)
04/2009
1Intestinal Obstruction (Obstruction, Intestinal)
12/2008
1Abscess
01/2005
1Anorexia
04/2004

Drug/Important Bio-Agent (IBA)

8Orotate PhosphoribosyltransferaseIBA
08/2008 - 07/2005
7EnzymesIBA
08/2008 - 07/2005
5Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
08/2008 - 08/2006
5Fluorouracil (Carac)FDA LinkGeneric
05/2008 - 07/2005
4Thymidylate SynthaseIBA
08/2008 - 01/2007
3Proteins (Proteins, Gene)FDA Link
07/2008 - 04/2006
3ImmunosorbentsIBA
10/2007 - 07/2005
2Thymidine PhosphorylaseIBA
08/2008 - 05/2008
2Paclitaxel (Taxol)FDA LinkGeneric
08/2008 - 05/2008
2Messenger RNA (mRNA)IBA
05/2008 - 08/2006
1Polytetrafluoroethylene (Teflon)FDA Link
04/2011
1Cisplatin (Platino)FDA LinkGeneric
11/2010
1Dihydrotachysterol (AT 10)IBA
04/2009
1Uridine PhosphorylaseIBA
08/2008
1Indicators and Reagents (Reagents)IBA
07/2008
1Antineoplastic Agents (Antineoplastics)IBA
05/2008
1doxifluridineIBA
05/2008
1Biological ProductsIBA
08/2006
1UracilIBA
06/2006
1TegafurIBA
06/2006
1BariumIBA
01/2005
1titanium silicide (TS-1)IBA
04/2004

Therapy/Procedure

9Drug Therapy (Chemotherapy)
08/2008 - 04/2004
5Gastrectomy
09/2005 - 07/2002
4Lymph Node Excision (Lymph Node Dissection)
01/2007 - 08/2000
2Neoadjuvant Therapy
11/2010 - 10/2007
1Fundoplication
04/2011
1Length of Stay
12/2010
1Central Venous Catheters
04/2009
1X-Ray Film
04/2009
1Total Parenteral Nutrition
04/2009
1Gastrostomy
12/2008
1Decompression
12/2008
1Appendectomy
12/2008
1Adjuvant Chemotherapy
07/2008
1Combination Drug Therapy (Combination Chemotherapy)
05/2008
1Esophagectomy
11/2007
1Oral Administration
06/2006
1Laparotomy
01/2005